Comparative Effect of Pursed Lip Breathing Alone and Combined With Alternate Nostril Breathing on Pulmonary Function Test and Quality of Life in Patients in Grade I COPD Patients.
1 other identifier
interventional
40
1 country
1
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory disorder characterized by airflow limitation, breathlessness, and reduced quality of life. Breathing exercises are commonly used in pulmonary rehabilitation to improve respiratory efficiency and functional capacity. Among these techniques, pursed lip breathing (PLB) helps slow expiration, reduce air trapping, and improve ventilation, while alternate nostril breathing (ANB), a yogic breathing technique, may enhance respiratory control and relaxation. The purpose of this study is to determine the effects of pursed lip breathing alone compared with the combined effect of pursed lip breathing and alternate nostril breathing on pulmonary function and quality of life in patients with Grade I COPD. This randomized controlled trial will include approximately 40 participants diagnosed with mild COPD. The participants will be divided into two groups: one group will perform pursed lip breathing exercises, while the other group will perform a combination of pursed lip breathing and alternate nostril breathing. Pulmonary function tests and quality of life assessments will be used as outcome measures to evaluate the effectiveness of these interventions. The study aims to determine whether combining both breathing techniques provides greater improvement in respiratory function and patient well being than pursed lip breathing alone. The findings may contribute to developing more effective physiotherapy based pulmonary rehabilitation strategies for patients with COPD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 28, 2026
CompletedFirst Submitted
Initial submission to the registry
April 6, 2026
CompletedFirst Posted
Study publicly available on registry
April 15, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 15, 2026
April 15, 2026
April 1, 2026
3 months
April 6, 2026
April 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulmonary Function Test
Pulmonary function will be assessed using a calibrated spirometer to evaluate lung function parameters, including forced vital capacity (FVC), forced expiratory volume in one second (FEV₁), and FEV₁/FVC ratio. The test will be performed according to standardized guidelines, with participants instructed to perform maximal inspiration followed by a forceful and sustained expiration into the spirometer.
04 weeks
Study Arms (2)
Pursed lip breathing exercises
ACTIVE COMPARATORParticipants in Group A will perform pursed lip breathing exercises. In this technique, patients are instructed to inhale slowly through the nose and then exhale slowly through pursed lips, as if blowing out a candle. The expiration phase is prolonged to help reduce air trapping and improve ventilation. The exercise will be performed under supervision for the prescribed duration and frequency during the intervention period.
Pursed lip breathing with alternate nostril breathing
EXPERIMENTALParticipants in Group B will perform a combination of pursed lip breathing and alternate nostril breathing. Along with PLB, patients will practice alternate nostril breathing, a controlled breathing technique in which inhalation and exhalation occur alternately through one nostril at a time while the other nostril is gently closed using the fingers. This technique helps regulate breathing patterns, improve respiratory control, and promote relaxation. The exercises will be performed under supervision according to the prescribed duration and frequency during the intervention period.
Interventions
Alternate Nostril Breathing (ANB): Alternate nostril breathing is a controlled breathing technique commonly used in yogic practices to regulate breathing patterns. In this method, the individual inhales through one nostril while the other is closed, then exhales through the opposite nostril in an alternating pattern. This technique promotes relaxation, improves respiratory control, and may enhance lung function.
Alternate nostril breathing is a simple technique where you inhale through one nostril and exhale through the other in a controlled pattern. It helps calm the mind and improves lung function. This breathing exercise can be beneficial in conditions like Chronic Obstructive Pulmonary Disease. Practicing it regularly enhances relaxation and balances the body.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with Grade I COPD (FEV₁ \> 80% predicted)
- Age between 40 to 65 years.
- Both male and female patients.
- Patients able to follow verbal instructions and perform breathing exercises.
- Patients willing to provide written informed consent.
You may not qualify if:
- History of orthopedic conditions limiting sitting or breathing exercises.
- Recent respiratory infections or COPD exacerbations within the past 4 weeks.
- Neurological or cognitive impairments.
- Recent thoracic or abdominal surgeries.
- Regular practitioners of yoga or alternate nostril breathing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foundation University Islamabad
Islamabad, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- In this study, single blinding will be applied. The outcome assessor will be blinded to the group allocation of the participants. This means that the person responsible for measuring and recording the outcomes, including the Pulmonary Function Test and questionnaire assessments, will not know whether the participant belongs to Group A (pursed lip breathing) or Group B (pursed lip breathing combined with alternate nostril breathing).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 6, 2026
First Posted
April 15, 2026
Study Start
February 28, 2026
Primary Completion (Estimated)
May 15, 2026
Study Completion (Estimated)
May 15, 2026
Last Updated
April 15, 2026
Record last verified: 2026-04